Found 241 results
Author Keyword [ Title(Desc)] Type Year
Filters: First Letter Of Keyword is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Perera T, Young MR, Zhang Z, Murphy G, Colburn NH, Lanza E, Hartman TJ, Cross AJ, Bobe G.  2015.  Identification and monitoring of metabolite markers of dry bean consumption in parallel human and mouse studies.. Mol Nutr Food Res. 59(4):795-806.
Perera T, Young MR, Zhang Z, Murphy G, Colburn NH, Lanza E, Hartman TJ, Cross AJ, Bobe G.  2015.  Identification and monitoring of metabolite markers of dry bean consumption in parallel human and mouse studies.. Mol Nutr Food Res. 59(4):795-806.
Krueger SK, Martin SR, Yueh M-F, Pereira CB, Williams DE.  2002.  Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein.. Drug Metab Dispos. 30(1):34-41.
Roemeling MD, Williams J, Beckman JS, Hurst JK.  2015.  Imidazole catalyzes chlorination by unreactive primary chloramines.. Free Radic Biol Med. 82:167-78.
Broekaert D, Leigh IM, Lane EB, Van Muijen GN, Ramaekers FC, De Bersaques J, Coucke P.  1993.  An immunohistochemical and histochemical study of cytokeratin, involucrin and transglutaminase in seborrhoeic keratosis.. Arch Dermatol Res. 285(8):482-90.
Ho E, Wong CP, King JC.  2022.  Impact of zinc on DNA integrity and age-related inflammation.. Free Radic Biol Med. 178:391-397.
Bobe G, Cobb TJ, Leonard SW, Aponso S, Bahro CB, Koley D, Mah E, Bruno RS, Traber MG.  2017.  Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.. Redox Biol. 12:121-128.
Lebold KM, Grant KA, Freeman WM, Wiren KM, Miller GW, Kiley C, Leonard SW, Traber MG.  2011.  Individual differences in hyperlipidemia and vitamin E status in response to chronic alcohol self-administration in cynomolgus monkeys.. Alcohol Clin Exp Res. 35(3):474-83.
Katchamart S, Williams DE.  2001.  Indole-3-carbinol modulation of hepatic monooxygenases CYP1A1, CYP1A2 and FMO1 in guinea pig, mouse and rabbit.. Comp Biochem Physiol C Toxicol Pharmacol. 129(4):377-84.
Tsao CS.  1991.  Inhibiting effect of ascorbic acid on the growth of human mammary tumor xenografts.. Am J Clin Nutr. 54(6 Suppl):1274S-1280S.
Zhang WJian, Frei B.  2003.  Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells.. Free Radic Biol Med. 34(6):674-82.
Zhang WJian, Frei B.  2003.  Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells.. Free Radic Biol Med. 34(6):674-82.
Zhang WJian, Frei B.  2003.  Intracellular metal ion chelators inhibit TNFalpha-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells.. Free Radic Biol Med. 34(6):674-82.
Li L, Frei B.  2006.  Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity.. Arterioscler Thromb Vasc Biol. 26(12):2638-43.
Zhang W-J, Wei H, Frei B.  2010.  The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice.. Exp Biol Med (Maywood). 235(5):633-41.
Zhang W-J, Wei H, Frei B.  2010.  The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice.. Exp Biol Med (Maywood). 235(5):633-41.
Zhang W-J, Wei H, Frei B.  2010.  The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice.. Exp Biol Med (Maywood). 235(5):633-41.
Zhang W-J, Wei H, Frei B.  2010.  The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice.. Exp Biol Med (Maywood). 235(5):633-41.

Pages